Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for BioMed Research International, enter your email address in the box below.

BioMed Research International
Volume 2014 (2014), Article ID 902492, 6 pages
http://dx.doi.org/10.1155/2014/902492
Research Article

The Association between Serological Biomarkers and Primary Sjogren’s Syndrome Associated with Peripheral Polyneuropathy

Che-Wei Hsu,1 Yu-Jih Su,2,3 Wen-Neng Chang,1 Nai-Wen Tsai,1 Wen-Chan Chiu,3 Ben-Chung Cheng,2,3 Chih-Min Su,2,4 Chi-Ren Huang,1 Ya-Ting Chang,1,2 and Cheng-Hsien Lu1,2

1Department of Neurology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, No. 123, Ta Pei Road, Niao Sung Hsiang, Kaohsiung 833, Taiwan
2Department of Biological Science, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan
3Department of Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung 833, Taiwan
4Department of Emergency Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung 833, Taiwan

Received 4 February 2014; Accepted 26 February 2014; Published 13 April 2014

Academic Editor: Hung-Chen Wang

Copyright © 2014 Che-Wei Hsu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Gono, Y. Kawaguchi, Y. Katsumata et al., “Clinical manifestations of neurological involvement in primary Sjögren's syndrome,” Clinical Rheumatology, vol. 30, no. 4, pp. 485–490, 2011. View at Publisher · View at Google Scholar
  2. K. Mori, M. Iijima, H. Koike et al., “The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy,” Brain, vol. 128, part 11, pp. 2518–2534, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. P. P. Pavlakis, H. Alexopoulos, M. L. Kosmidis et al., “Peripheral neuropathies in Sjögren's syndrome: a critical update on clinical features and pathogenetic mechanisms,” Journal of Autoimmunity, vol. 39, no. 1-2, pp. 27–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. R. A. Wright, I. A. Grant, and P. A. Low, “Autonomic neuropathy associated with sicca complex,” Journal of the Autonomic Nervous System, vol. 75, no. 1, pp. 70–76, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Hebbar, K. Hebbar-Savean, E. Hachulla, M. Brouillard, P. Y. Hatron -, and B. Devulder, “Participation of cryoglobulinaemia in the severe peripheral neuropathies of primary Sjögren's syndrome,” Annales de Medecine Interne, vol. 146, no. 4, pp. 235–238, 1995. View at Google Scholar · View at Scopus
  6. E. L. Alexander, M. R. Ranzenbach, A. J. Kumar et al., “Anti-Ro(SS-A) autoantibodies in central nervous system disease associated with Sjögren's syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates,” Neurology, vol. 44, no. 5, pp. 899–908, 1994. View at Google Scholar · View at Scopus
  7. C. Vitali, S. Bombardieri, R. Jonsson et al., “Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group,” Annals of the Rheumatic Diseases, vol. 61, no. 6, pp. 554–558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Harboe, A. B. Tjensvoll, S. Maroni et al., “Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study,” Annals of the Rheumatic Diseases, vol. 68, no. 10, pp. 1541–1546, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Delalande, J. de Seze, A. L. Fauchais et al., “Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients,” Medicine, vol. 83, no. 5, pp. 280–291, 2004. View at Google Scholar
  10. R. Cervera and R. A. Asherson, “Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics,” Immunobiology, vol. 210, no. 10, pp. 735–741, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Cervera, R. A. Asherson, M. L. Acevedo et al., “Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients,” Annals of the Rheumatic Diseases, vol. 63, no. 10, pp. 1312–1317, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Sène, J. C. Piette, and P. Cacoub, “Antiphospholipid antibodies, antiphospholipid syndrome and viral infections,” Revue de Medecine Interne, vol. 30, no. 2, pp. 135–141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Sène, J. C. Piette, and P. Cacoub, “Antiphospholipid antibodies, antiphospholipid syndrome and infections,” Autoimmunity Reviews, vol. 7, no. 4, pp. 272–277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. R. D. Franklin, N. Hollier, and W. H. Kutteh, “β2-glycoprotein 1 as a marker of antiphospholipid syndrome in women with recurrent pregnancy loss,” Fertility and Sterility, vol. 73, no. 3, pp. 531–535, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. W. H. Chen, “Anti-β2-glycoprotein I antibody and hypertension in cerebral ischemia,” Clinical and Applied Thrombosis/Hemostasis, vol. 10, no. 1, pp. 55–60, 2004. View at Google Scholar · View at Scopus
  16. W. H. Chen and J. S. Liu, “An unusual increase of blood anti-β2-glycoprotein-I antibody but not antiphospholipid antibody in cerebral ischemia: a case report,” Angiology, vol. 52, no. 2, pp. 149–154, 2001. View at Google Scholar · View at Scopus
  17. L. Frohman, R. Turbin, L. Bielory, L. Wolansky, W. C. Lambert, and S. Cook, “Autoimmune optic neuropathy with anticardiolipin antibody mimicking multiple sclerosis in a child,” The American Journal of Ophthalmology, vol. 136, no. 2, pp. 358–360, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. W. H. Chen and C. J. Chen, “Antiphospholipid antibody, head-shaking and ataxia: an evidence of non-vascular neurotoxicity and successful treatment by plasmapheresis,” Rheumatology International, vol. 29, no. 7, pp. 827–829, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Ishikawa and M. Kobayashi, “Recurrent acute cerebellar ataxia associated with anti-cardiolipin antibodies,” Brain and Development, vol. 32, no. 7, pp. 588–591, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. J. H. Friedman, “Dementia, ataxia and parkinsonism associated with the antiphospholipid syndrome,” Parkinsonism and Related Disorders, vol. 17, no. 3, pp. 215–216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. W. H. Chen, H. L. Yin, and C. J. Chen, “Anti-β2-glycoprotein I antibody and cerebellar ataxia in breast cancer,” Lupus, vol. 21, no. 4, pp. 460–462, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Jayne, “Review article: progress of treatment in ANCA-associated vasculitis,” Nephrology, vol. 14, no. 1, pp. 42–48, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. R. A. Sinico, C. Pozzi, A. Radice, and A. Tincani, “ANCA with specificity for lactoferrin in systemic lupus erythematosus (SLE),” Advances in Experimental Medicine and Biology, vol. 336, pp. 385–387, 1993. View at Google Scholar · View at Scopus
  24. J. Font, M. Ramos-Casals, R. Cervera et al., “Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome: prevalence and clinical significance,” The British Journal of Rheumatology, vol. 37, no. 12, pp. 1287–1291, 1998. View at Google Scholar · View at Scopus
  25. M. Alpa, B. Ferrero, R. Cavallo et al., “Anti-GM1 and anti-sulfatide antibodies in patients with systemic lupus erythematosus, Sjögren's syndrome, mixedcryoglobulinemia and idiopathic systemic vasculitis,” Clinical and Experimental Rheumatology, vol. 25, no. 4, pp. 556–562, 2007. View at Google Scholar · View at Scopus
  26. C. Foguem, B. Kantelip, E. Deconinck et al., “Kappa light chain deposition disease, presenting as Sjögren's syndrome, successfully treated by high-dose melphalan and autologous blood stem transplantation,” Revue de Medecine Interne, vol. 30, no. 1, pp. 49–52, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Rodier and J. C. Weber, “Peripheral neuropathy in primary Sjögren's syndrome,” Revue de Medecine Interne, vol. 17, no. 7, pp. 558–562, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Kessenbrock, M. Krumbholz, U. Schönermarck et al., “Netting neutrophils in autoimmune small-vessel vasculitis,” Nature Medicine, vol. 15, no. 6, pp. 623–625, 2009. View at Publisher · View at Google Scholar · View at Scopus